Clinical trial · Interventional
Pilot Study of Intervention to Reduce Sunburns in Melanoma Survivors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Converted from a pilot into a larger study which we will enter as a new protocol
Summary
Brief summary (as posted)
This project will pilot test whether a wearable device that tracks sun exposure and provides alerts regarding sun exposure and protection behaviors will reduce sunburns in melanoma survivors. The use of wearable technology devices has grown quickly over the last decade and studies using these devices to promote physical activity and weight loss have been promising. The investigators will pilot test the technology device versus a similar control device in 80 melanoma survivors and compare sunburns between the two groups after the three month intervention.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Melanoma (Skin) | Melanoma | ONTOLOGY_EXACT | 0.85 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Microsoft Band 2 | Device | — | UNRESOLVED |
| Microsoft Band 2 + UV messaging | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Intervention
- description
- Microsoft Band 2 application with UV messaging activated
- interventionNames
- Device: Microsoft Band 2 + UV messaging
- type
- ACTIVE_COMPARATOR
- label
- Control
- description
- Microsoft Band 2 application (UV messaging not active)
- interventionNames
- Device: Microsoft Band 2
Primary outcomes (1)
- measure
- Sunburn
- timeFrame
- 3 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * 18-75 years old * Diagnosed with stage I-III cutaneous invasive melanoma between 2009 and 2017 and treated at the University of Minnesota * Able to read/write in English * Own a smartphone * Able to provide voluntary informed consent Exclusion Criteria: -Patients currently undergoing adjuvant therapy.
References
Publications (0)
Data not yet available